Continuum Advisory, LLC Dexcom Inc Transaction History
Continuum Advisory, LLC
- $760 Million
- Q4 2024
A detailed history of Continuum Advisory, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Continuum Advisory, LLC holds 295 shares of DXCM stock, worth $26,523. This represents 0.0% of its overall portfolio holdings.
Number of Shares
295
Previous 293
0.68%
Holding current value
$26,523
Previous $19,000
15.79%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DXCM
# of Institutions
1,082Shares Held
351MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4.18 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.1 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.5 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.31 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.29 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.7B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...